Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.

Guidelines: Production

Production covers all operations involved in the preparation of a pharmaceutical product, from receipt of materials, through processing, packaging and repackaging, labelling and relabelling, to completion of the finished product. 

WHO good manufacturing practices  

Good manufacturing practice (GMP) is that part of a quality management system to ensure that products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorization. GMP is aimed primarily at diminishing the risks inherent in any pharmaceutical production; which may broadly be categorized into two groups: (1) cross-contamination/mix-ups and (2) false labelling. Above all, manufacturers must not place patients at risk due to inadequate safety, quality or efficacy.  For this reason, risk assessment has come to play an important role in WHO quality assurance guidelines.

 

Related documents

15 April 2025

TRS 1060 - Annex 4: Good practices for blood establishments

15 April 2025

TRS 1060 - Annex 3: WHO good manufacturing practices for excipients used in pharmaceutical products

15 April 2025

TRS 1060 - Annex 2: WHO good practice considerations for the prevention and control of nitrosamines in pharmaceutical products

26 April 2024

TRS 1052 - Annex 3: IAEA/WHO good manufacturing practices for in house cold kits for radiopharmaceutical preparations

26 April 2024

TRS 1052 - Annex 2: WHO good manufacturing practices for excipients used in pharmaceutical products

14 November 2022

TRS 1044 - Annex 5: WHO good manufacturing practices for medicinal gases

31 October 2022

TRS 1044 - Annex 2: WHO good manufacturing practices for sterile pharmaceutical products

30 September 2022

TRS 1044 - Annex 6: WHO good practices for research and development facilities of pharmaceutical products

31 August 2022

TRS 1044 - Annex 7: WHO good manufacturing practices for investigational products

31 July 2022

TRS 1044 - Annex 3: IAEA/WHO guideline on good manufacturing practices for investigational

30 April 2022

TRS 1044 - Annex 4: WHO guidelines on technology transfer in pharmaceutical manufacturing

17 November 2021

TRS 1033 - Annex 3: Good manufacturing practices: water for pharmaceutical use

10 October 2021

TRS 1033 - Annex 4: WHO Guideline on data integrity

10 October 2021

TRS 1033 - Annex 2: Points to consider when including Health-Based Exposure Limits (HBELs) in cleaning validation

30 September 2020

TRS 1025 - Annex 2: IAEA - WHO good manufacturing practices for radiopharmaceutical products

20 April 2020

TRS 1025 - Annex 3: Production of water for injection by means other than distillation

20 April 2020

TRS 1025 - Annex 6: Points to consider for manufacturers and inspectors: environmental aspects of manufacturing for the prevention of antimicrobial resistance

30 September 2019

TRS 1019 - Annex 2: WHO good manufacturing practices for heating, ventilation and air-conditioning systems for non-sterile pharmaceutical products (part 2): interpretation of guidelines

25 January 2019

TRS 1019 - Annex 3: Good manufacturing practices: guidelines on validation

10 October 2018

TRS 1010 - Annex 8: Guidelines on heating, ventilation and air-conditioning systems for non-sterile pharmaceutical products

30 September 2018

TRS 1010 - Annex 2: WHO good manufacturing practices for the manufacture of herbal medicines

30 September 2018

TRS 1010 - Annex 1: WHO good manufacturing practices for the manufacture of herbal medicines

14 April 2016

TRS 996 - Annex 3: WHO good manufacturing practices for biological products (jointly with the Expert Committee on Biological Standardization)

31 October 2015

TRS 992 - Annex 4: General guidance on hold-time studies

1 October 2014

TRS 986 - Annex 2: WHO good manufacturing practices for pharmaceutical products: Main principles

25 January 2013

TRS 981 - Annex 2: WHO guidelines on quality risk management

30 September 2011

TRS 961 - Annex 4: WHO good manufacturing practices for blood establishments (jointly with the Expert Committee on Biological Standardization)

1 October 2010

TRS 957 - Annex 2: WHO good manufacturing practices for active pharmaceutical ingredients (bulk drug substances)

30 September 2010

TRS 957 - Annex 3: WHO good manufacturing practices for pharmaceutical products containing hazardous substances

30 September 2010

TRS 957 - Annex 7: WHO guidelines for the preparation of a contract research organization master file

10 October 2002

TRS 902 - Annex 9: Guidelines on packaging for pharmaceutical products